Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia

• Status: Unknown status
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine the efficacy and safety of Botulax® in treatment of cervical dystonia

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hugel
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A

Criteria

Inclusion Criteria:

1. Male or female of aged over 19 years

2. Subjects diagnosed with primary cervical dystonia

Exclusion Criteria:

1. Subjects who have administered botulinum toxin within 16 weeks at the time of baseline

2. Pregnant or nursing

3. Females or males who do not agree on proper contraceptive measure